Kobayashi M - Search Results

1

Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies.

Shigeno K, Naito K, Sahara N, Kobayashi M, Nakamura S, Fujisawa S, Shinjo K, Takeshita A, Ohno R, Ohnishi K. Shigeno K, et al. Among authors: kobayashi m. Int J Hematol. 2005 Oct;82(3):224-9. doi: 10.1532/IJH97.05044. Int J Hematol. 2005. PMID: 16207595 Clinical Trial.

2

Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway.

Sahara N, Takeshita A, Kobayashi M, Shigeno K, Nakamura S, Shinjo K, Naito K, Maekawa M, Horii T, Ohnishi K, Kitamura K, Naoe T, Hayash H, Ohno R. Sahara N, et al. Among authors: kobayashi m. Leuk Lymphoma. 2004 May;45(5):987-95. doi: 10.1080/10428190310001617222. Leuk Lymphoma. 2004. PMID: 15291359

3

Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components.

Nakamura S, Nakamura R, Shibata K, Kobayashi M, Sahara N, Shigeno K, Shinjo K, Naito K, Ohnishi K, Kasahara N, Iwaki Y. Nakamura S, et al. Among authors: kobayashi m. Eur J Haematol. 2004 Oct;73(4):285-94. doi: 10.1111/j.1600-0609.2004.00290.x. Eur J Haematol. 2004. PMID: 15347316

4

Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells.

Nakamura S, Kobayashi M, Shibata K, Sahara N, Shigeno K, Shinjo K, Naito K, Hayashi H, Ohnishi K. Nakamura S, et al. Among authors: kobayashi m. Leuk Res. 2006 Feb;30(2):123-35. doi: 10.1016/j.leukres.2005.06.009. Epub 2005 Jul 25. Leuk Res. 2006. PMID: 16046235

5

Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells.

Kobayashi M, Nakamura S, Shibata K, Sahara N, Shigeno K, Shinjo K, Naito K, Ohnishi K. Kobayashi M, et al. Eur J Haematol. 2005 Sep;75(3):212-20. doi: 10.1111/j.1600-0609.2005.00498.x. Eur J Haematol. 2005. PMID: 16104877

6

Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatment.

Shinjo K, Takeshita A, Sahara N, Kobayashi M, Nakamura S, Shigeno K, Naito K, Maekawa M, Ohnishi K, Ohno R. Shinjo K, et al. Among authors: kobayashi m. Intern Med. 2005 Aug;44(8):818-24. doi: 10.2169/internalmedicine.44.818. Intern Med. 2005. PMID: 16157979 Free article.

7

Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56- and CD56+ multiple myeloma cells.

Sahara N, Takeshita A, Ono T, Sugimoto Y, Kobayashi M, Shigeno K, Nakamura S, Shinjo K, Naito K, Shibata K, Otsuki T, Hayashi H, Ohnishi K. Sahara N, et al. Among authors: kobayashi m. Exp Hematol. 2006 Jun;34(6):736-44. doi: 10.1016/j.exphem.2006.02.012. Exp Hematol. 2006. PMID: 16728278 Free article.

8

Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy.

Naito K, Kobayashi M, Sahara N, Shigeno K, Nakamura S, Shinjo K, Tobita T, Takeshita A, Ohno R, Ohnishi K. Naito K, et al. Among authors: kobayashi m. Int J Hematol. 2006 May;83(4):318-23. doi: 10.1532/IJH97.05056. Int J Hematol. 2006. PMID: 16757431

9

Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma.

Sahara N, Ohnishi K, Ono T, Sugimoto Y, Kobayashi M, Takeshita K, Shigeno K, Nakamura S, Naito K, Tamashima S, Nara K, Tobita T, Takeshita A, Ohno R. Sahara N, et al. Among authors: kobayashi m. Eur J Haematol. 2006 Jul;77(1):14-8. doi: 10.1111/j.1600-0609.2006.00661.x. Eur J Haematol. 2006. PMID: 16827882

10

Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide.

Fujisawa S, Ohno R, Shigeno K, Sahara N, Nakamura S, Naito K, Kobayashi M, Shinjo K, Takeshita A, Suzuki Y, Hashimoto H, Kinoshita K, Shimoya M, Kaise T, Ohnishi K. Fujisawa S, et al. Among authors: kobayashi m. Cancer Chemother Pharmacol. 2007 Mar;59(4):485-93. doi: 10.1007/s00280-006-0288-4. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,144 results

Search Page

Filters